City of Hope Gives von Gunten Humanitarian Award

 

January 28, 2008  |  

Charles von Gunten, M.D., Ph.D., Associate Clinical Professor of Medicine at UCSD, is the 2007 recipient of the Sarnat Distinguished Humanitarian Award, given by the City of Hope Comprehensive Cancer Center in recognition of outstanding scientific and humanitarian achievement in hospice and palliative care. 

Charles von Gunten, M.D., Ph. D.

Charles von Gunten, M.D., Ph. D.

Von Gunten is a member of the Moores UCSD Cancer Center, and medical director of the Doris A. Howell Service, a clinical consultation service for palliative and supportive care, which is based at the Cancer Center. He holds an established investigator award from the National Cancer Institute and is editor-in-chief of the Journal of Palliative Medicine. He also holds the position of Provost of the Center for Palliative Studies at San Diego Hospice & Palliative Care, which sponsors the largest fellowship program in palliative medicine in the U.S.  

This is the 12th year the Sarnat award has been given by the City of Hope Comprehensive Cancer Center in Duarte, California.

###

Media Contact: Nancy Stringer, 619-543-6163, nstringer@ucsd.edu


Related Specialties

UCSD Moores Cancer Center


Media Contact

Share This Article


Related News

1/18/2018
Catherine M. Robertson, MD, has been named chief of Sports Medicine at UC San Diego Health. Robertson, a board-certified orthopedic surgeon who specializes in treating injuries of the shoulder, knee a ...
1/17/2018
Confirming earlier computational models, researchers at University of California San Diego and UC San Diego School of Medicine, with colleagues in Arizona and Louisiana, report that episodic memories ...
1/11/2018
UC San Diego Health and Eisenhower Health signed a five-year affiliation agreement to expand cancer services for residents of Coachella Valley. Starting in January 2018, as a member of the UC San Dieg ...
1/11/2018
An international team, led by researchers at the University of California San Diego School of Medicine, has developed and validated a genetic tool for predicting age of onset of aggressive prostate ca ...



Follow Us